MS

Manmohan Singh Phull

Active Director Director DIN 00066453
DIN 00066453 First appointment Jan 2001 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2001
Shareholding value •••• Premium profile

About Manmohan Singh Phull

Data last updated:

Manmohan Singh Phull is a Director at Synorga Pharmaceuticals Ltd (since 2001). The company operates in Trading. Synorga Pharmaceuticals Ltd reported revenue of ₹18.90 Cr (FY 2017).

DIN 00066453
Primary Designation Director
Industry Trading
First Appointment 30 Jan 2001
Oldest Company Age 45 yrs
Largest company Synorga Pharmaceuticals Ltd · ₹18.90 Cr (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synorga Pharmaceuticals Ltd U24230DL1981PLC011952
Director30 Jan 20011981₹18.90 Cr (FY 2017)Active

Board colleagues of Manmohan Singh Phull

Directorship timeline

Open interactive timeline →
Synorga Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Manmohan Singh Phull

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manmohan Singh Phull

Manmohan Singh Phull currently holds 1 directorship: Synorga Pharmaceuticals Ltd (Director, since 30 Jan 2001, revenue ₹18.90 Cr (FY 2017)).

Manmohan Singh Phull was first appointed on 30 Jan 2001 as Director at Synorga Pharmaceuticals Ltd.

The current boards of Manmohan Singh Phull's companies include Kultaran Singh Kochhar (Synorga Pharmaceuticals Ltd), Surinder Singh (Synorga Pharmaceuticals Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available